For Research Purposes Only · Not For Human Consumption

Home/Buy/Retatrutide 30mg
Summer Sale · 30% Off
Retatrutide 30mg vial
Third-party tested
CoA available
UK dispatched

Metabolic Research

Buy Retatrutide 30mg UK | Research Grade

The single-lot vial for long programmes. 30mg of Retatrutide (LY3437943) from one synthesis, so a multi-arm study runs start to finish without a lot change — and at the lowest cost per milligram we list.

£134.99

£192.84

In stock

Inc. VAT · Free UK shipping on this order

1
Order before 6pm Monday for same-day dispatch

SSL encrypted · Lot-traceable to its CoA

Delivery.
£3.99 Royal Mail Tracked 24, free over £50. Order before 6pm GMT on a working day and it ships the same day — most UK mainland addresses arrive the next working day. Delivery details
Payment.
UK bank transfer via Fena Open Banking — you approve it inside your own banking app. We never see or store your card or bank details.
If it's not right.
14 days to change your mind while the vial is unopened and sealed. Damaged, leaking or incorrect items are replaced or refunded at our cost. Returns policy
Verification.
Independently HPLC-tested. Lot-matched CoA available on request — quote your batch and order ID.

About this lot

  • Tested by an independent labJanoshik Analytical or Aspen Bioanalytics — not tested in-house by us.
  • Held and dispatched in the UKManchester stock, Royal Mail Tracked 24, no overseas customs step.
  • Research use onlyUnlicensed compound, not approved by the MHRA for human use.
How we verify what we publish →

What you receive

  • 011 × Retatrutide 30mg — lyophilised, sealed glass vial
  • 02Signed CoA by email — batch this lot, HPLC-UV + mass-spec. Sent with your confirmation, not enclosed in the parcel.
  • 03Royal Mail Tracked 24 — same-day dispatch before 6pm, Mon–Fri
Research Compound

About Retatrutide

The 30mg presentation exists for one reason: continuity. A study that spans several months on 10mg vials will cross three or four lots, and every lot boundary introduces a variable you then have to control for — or explain in your methods section. Thirty milligrams from a single synthesis covers a full multi-arm protocol on one lot number, one certificate, one set of analytical assumptions. For dose–response work across parallel conditions, that removes inter-batch variability from the design entirely rather than correcting for it afterwards. Synthesis, purity standard and third-party verification are identical to the 10mg and 20mg vials. The only differences are the fill weight, the cost per milligram, and how long a single lot lasts. UK Peptides supplies retatrutide strictly for in-vitro and preclinical laboratory research. This compound is not approved for human use and is not a licensed medicine.

Research areas

  • Multi-arm dose–response designs on one lot
  • Parallel-condition receptor pharmacology
  • Longitudinal adipocyte & hepatocyte assays
  • Cross-compound comparison panels
Compound Profile

Retatrutide 30mg — mechanism, research applications & compound data

Retatrutide 30mg is the single-lot vial: enough LY3437943 from one synthesis to carry a multi-arm protocol from first plate to final readout without a lot change. Where the 10mg vial suits a discrete experiment and the 20mg an extended one, the 30mg exists for studies long enough that crossing a batch boundary would otherwise become a variable you have to control for.

01

Retatrutide 30mg UK — one lot for the whole study

A protocol running several months on 10mg vials will consume three or four lots before it finishes. Each boundary is a new certificate, a new set of analytical assumptions, and a confound that has to be either designed around or disclosed. Thirty milligrams from one synthesis removes that entirely: one lot number, one certificate, one set of assumptions for the duration. This page is the 30mg vial specifically — for a discrete experiment see the Retatrutide 10mg vial, and for an extended single-arm protocol the Retatrutide 20mg.

02

Why inter-batch variability matters in receptor pharmacology

Two lots of the same peptide, both certified at ≥98% HPLC purity, can still differ inside that specification — in the identity of the residual 2%, in water content after lyophilisation, in aggregation behaviour on reconstitution. For a single-condition assay that difference is usually immaterial. For a dose–response series compared across arms, it sits underneath every number you report. Running one lot end to end does not correct for that variability; it means it was never introduced.

03

Study designs the 30mg vial is built for

The vial suits work where consistency across conditions matters more than the size of any single experiment:

  • Multi-arm dose–response series compared against one another
  • Parallel-condition GPCR signalling panels (cAMP, β-arrestin, ERK1/2)
  • Longitudinal adipocyte and hepatocyte assays spanning months
  • Head-to-head panels against tirzepatide and semaglutide
  • Replication arms that must be traceable to the same synthesis
  • Method development where the compound has to be the fixed variable
04

Reconstitution and working volumes for a 30mg vial

The larger fill changes the arithmetic rather than the method. Reconstitute with bacteriostatic water (0.9% benzyl alcohol) — commonly 3ml per 30mg vial for a 10mg/ml stock, adding solvent down the side of the vial without agitation. Because a 30mg vial is typically drawn from over a longer period than a 10mg, plan aliquoting at the point of reconstitution: the 28-day refrigerated window at 2–8°C applies from reconstitution, not from first use, and the solution must not be refrozen.

05

Identical synthesis, different fill weight

Nothing about the compound changes across our three vial sizes. Same synthesis route, same ≥98% HPLC-UV purity standard, same mass-spectrometry identity confirmation, same independent laboratories. What changes is the fill weight, the cost per milligram, and how long one lot number lasts. Anyone cross-referencing results between our 10mg, 20mg and 30mg vials is comparing the same material at different scales.

06

Certificate of Analysis for the 30mg lot

The 10mg and 20mg vials each have a signed third-party certificate published on their product page. The 30mg lot is a newer fill and its certificate is not yet published here. Email us with your order ID and we will send the lot-matched documentation we hold for it. We would rather say that plainly than show a download that does not exist — every certificate we publish is the unedited document for the exact lot dispatched.

07

Cost per milligram and UK dispatch

The 30mg vial carries the lowest per-milligram cost of the three presentations, which matters most on exactly the long protocols it is intended for. Dispatch is unchanged: orders before 6pm GMT on a working day leave Manchester the same day by Royal Mail Tracked 24, in an insulated mailer with ice packs. No overseas customs step, no anonymous fulfilment, and a UK registered address behind the sale.

Related search terms

  • retatrutide 30mg uk
  • buy retatrutide 30mg
  • retatrutide 30mg for sale uk
  • reta 30mg
  • LY3437943 30mg
  • single lot retatrutide vial
  • retatrutide 30mg vial
  • bulk retatrutide research uk
References & further reading

Primary sources cited on this page

Same compound as the 10mg and 20mg vials — LY3437943, a 39-residue synthetic peptide triple agonist of the GCGR, GIP and GLP-1 receptors developed by Eli Lilly, investigational and unlicensed. The 30mg fill exists so that a study spanning several months can be run on one lot number rather than three.

Peer-reviewed literature & regulatory records

  1. [1] Coskun et al., discovery and preclinical characterisation of LY3437943
    Cell Metabolism, 2022;34:1234-1247
  2. [2] Jastreboff et al., 'Triple–Hormone-Receptor Agonist Retatrutide for Obesity'
    New England Journal of Medicine, 2023;389:514-526
  3. [3] ICH Q1A(R2) — stability testing of new drug substances
    International Council for Harmonisation, guideline
  4. [4] TRIUMPH Phase 3 programme
    ClinicalTrials.gov
  5. [5] PubChem compound record (LY3437943)
    NCBI PubChem CID 156588324

Regulatory & compliance notice

This product is supplied strictly for in-vitro laboratory research. It is not a licensed medicine in the United Kingdom, is not approved by the Medicines and Healthcare products Regulatory Agency (MHRA) or the European Medicines Agency for human or veterinary use, and is not intended to diagnose, treat, cure or prevent any disease. Nothing on this page constitutes medical advice.

External links point to primary literature or regulatory records and open in a new tab. Citations are provided so the reader can independently verify every factual claim made on this page. Last reviewed 22 July 2026.

Certificate of Analysis

Retatrutide 30mg

No certificate is published for this item yet. Email us with your order ID and we will send the lot-matched documentation we hold for it.

Storage & handling

Keep it stable, keep it sterile

Storage: Store lyophilised powder at -20°C in a sealed vial. Protect from light and moisture. Allow the vial to reach room temperature before opening to prevent condensation entering the vial. Do not store in a frost-free freezer. Reconstitution: Reconstitute using bacteriostatic water (0.9% benzyl alcohol). Add solvent slowly down the side of the vial — do not shake. Allow to dissolve gently at room temperature. Reconstituted stability: Once reconstituted, store at 2–8°C (refrigerated). Use within 28 days. Do not refreeze after reconstitution. Shipping: All vials are dispatched in insulated mailers with ice packs to maintain cold chain during Royal Mail Tracked 24 transit.
+ Add Bacteriostatic Water (£4.99) →
FAQ

Retatrutide 30mg — common questions

Research Library

Further reading on Retatrutide

Peer-referenced articles from our research library covering mechanism, evidence and handling.

Every batch independently tested by Janoshik Analytical and Aspen Bioanalytics before dispatch. The signed certificate for your lot is supplied against your order ID.

Third-party HPLC-UV testing Lot-matched CoA on every order Batch-traceable from dispatch

Legal notice

This product is sold strictly for in-vitro laboratory research purposes only. It is not approved for human or veterinary use, is not a drug, food, or cosmetic, and should not be misused as such. UK Peptides accepts no liability for misuse. By purchasing you confirm you are a qualified researcher aged 18 or over.

Retatrutide 30mg

£134.99£192.84